Paradigm Medical Industries, Inc. carries a market capitalization of 324,879.00, placing it among publicly traded companies globally. Its enterprise value stands at 1.90M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 324,879.00 |
| Enterprise Value | 1.90M |
Paradigm Medical Industries, Inc. currently has 5.18M shares outstanding.
| Shares Outstanding | 5.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.00, and the price-to-book ratio stands at -NaN.
| PE Ratio | N/A |
| PS Ratio | 0.00 |
| PB Ratio | -NaN |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | 0.00 |
| P/OCF Ratio | 0.00 |
| EV / Sales | 1.61 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Paradigm Medical Industries, Inc. maintains a current ratio of 0.29, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -53.96, indicating conservative leverage, while an interest coverage ratio of -6.46 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.29 |
| Quick Ratio | 0.05 |
| Debt / Equity | -53.96 |
| Debt / EBITDA | -2.24 |
| Interest Coverage | -6.46 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -99.80 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.81 |
Paradigm Medical Industries, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Paradigm Medical Industries, Inc. generated 1.18M in revenue and converted that into -1.47M in net income, yielding earnings per share of -2.48. EBITDA reached -866,000.00, while operating income came in at -870,000.00.
| Revenue | 1.18M |
| Gross Profit | 549,000.00 |
| Operating Income | -870,000.00 |
| Pretax Income | -1.47M |
| Net Income | -1.47M |
| EBITDA | -866,000.00 |
| EBIT | -870,000.00 |
| Earnings Per Share (EPS) | -2.48 |
Paradigm Medical Industries, Inc. holds 44,000.00 in cash and equivalents against 1.94M in total debt, resulting in a net debt position of 1.90M. Total book value stands at -61.90M, with working capital of -2.00M providing operational flexibility.
| Cash & Cash Equivalents | 44,000.00 |
| Total Debt | 1.94M |
| Net Debt | 1.90M |
| Equity (Book Value) | -61.90M |
| Book Value Per Share | -104.92 |
| Working Capital | -2.00M |
Paradigm Medical Industries, Inc. produced -296,000.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -296,000.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -296,000.00 |
| FCF Per Share | -0.50 |
Paradigm Medical Industries, Inc. operates with a gross margin of 46.45, reflecting its pricing power and cost economics. The operating margin of -73.60 and net profit margin of -124.03 provide insight into operational efficiency.
| Gross Margin | 46.45 |
| Operating Margin | -73.60 |
| Pretax Margin | -124.03 |
| Profit Margin | -124.03 |
| EBITDA Margin | -73.27 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1.95M |
| FCF Yield | -1.86M |
Paradigm Medical Industries, Inc.'s most recent stock split took place on February 3, 2011 with a 100:1 split ratio.
| Last Split Date | 2/3/2011 |
| Split Ratio | 100:1 |
Paradigm Medical Industries, Inc. posts an Altman Z-Score of -110.62, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -110.62 |